Yuxi Zhu

Treatment regimen determines whether an HIF-1 inhibitor enhances or inhibits the effect of radiation therapy

M. Hiraoka, Xuejun Xie, S. Itasaka, 2009, British Journal of Cancer.

HIF-1-mediated metabolic reprogramming reduces ROS levels and facilitates the metastatic colonization of cancers in lungs

M. Yoshimura, M. Hiraoka, S. Itasaka, 2014, Scientific Reports.

UCHL1 provides diagnostic and antimetastatic strategies due to its deubiquitinating effect on HIF-1α

M. Sonobe, H. Date, M. Yoshimura, 2015, Nature Communications.